Nuvation Bio NUVB Investments - Gross Unrealized Losses
Investments - Gross Unrealized Losses at other companies
Other financials
Where this comes from
Reported directly by Nuvation Bio in its filing.
Tagged under the XBRL concept us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition.
The official record: Nuvation Bio’s 10-K, filed March 2, 2026, on SEC EDGAR. View the filing →
Ask your AI about Nuvation Bio's investments - gross unrealized losses.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Nuvation Bio's investments - gross unrealized losses?
- Nuvation Bio (NUVB) reported investments - gross unrealized losses of $18.16M in Q4 2025.
- How has Nuvation Bio's investments - gross unrealized losses changed year-over-year?
- Nuvation Bio's investments - gross unrealized losses decreased by 90.3% year-over-year, from $186.93M to $18.16M.
- What is the long-term trend for Nuvation Bio's investments - gross unrealized losses?
- Over 4 years (2021 to 2025), Nuvation Bio's investments - gross unrealized losses has grown at a -56.8% compound annual growth rate (CAGR), from $523.28M to $18.16M.